Rationale for adjunctive treatment targeting multiple mechanisms in schizophrenia

BJ Kinon, S Leucht, C Tamminga, A Breier… - The Journal of …, 2024 - psychiatrist.com
Importance: Schizophrenia is a complex syndrome with taxing symptoms and for which
treatment challenges remain. Current dopamine D 2 receptor–blocking antipsychotics have …

[HTML][HTML] EEG Techniques with Brain Activity Localization, Specifically LORETA, and Its Applicability in Monitoring Schizophrenia

A Zeltser, A Ochneva, D Riabinina… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Electroencephalography (EEG) is considered a standard but
powerful tool for the diagnosis of neurological and psychiatric diseases. With modern …

[HTML][HTML] Microstate D as a Biomarker in Schizophrenia: Insights from Brain State Transitions

R Yao, M Song, L Shi, Y Pei, H Li, S Tan, B Wang - Brain Sciences, 2024 - mdpi.com
Objectives. There is a significant correlation between EEG microstate and the
neurophysiological basis of mental illness, brain state, and cognitive function. Given that the …

Association between auditory P300 event-related potential and suicidal thoughts and behaviors in first-episode antipsychotic-naïve patients with schizophrenia

S Li, C Lu, N Liu, Y Li, X Wang, S Li, J Li… - Schizophrenia Research, 2024 - Elsevier
Objective Suicidal thoughts and behaviors (STBs) are critical concern in schizophrenia (SZ).
Concurrent changes in event-related potential (ERP), particularly the P300 (P3) …

[HTML][HTML] Prospects of Electrocorticography in Neuropharmacological Studies in Small Laboratory Animals

YI Sysoev, SV Okovityi - Brain Sciences, 2024 - mdpi.com
Electrophysiological methods of research are widely used in neurobiology. To assess the
bioelectrical activity of the brain in small laboratory animals, electrocorticography (ECoG) is …

Human neuroimaging and antipsychotic neurobiology at millisecond temporal resolution

DP Eisenberg, KF Berman - 2024 - nature.com
Antipsychotic medications at therapeutic concentrations remain the foundation of standard-
of-care first-line pharmacotherapies for schizophrenia spectrum illness [1]. However …

[HTML][HTML] Low-frequency EEG power and coherence differ between drug-induced parkinsonism and Parkinson's disease

S Seo, S Kim, SP Kim, J Kim, SY Kang… - Clinical Neurophysiology, 2024 - Elsevier
Objective Drug-induced parkinsonism (DIP) ranks second to Parkinson's disease (PD) in
causing parkinsonism. Despite sharing similar symptoms, DIP results from exposure to …

Electrophysiological Markers Predicting Antipsychotic Treatment Response in Patients with Schizophrenia: A Retrospective Study

S Yang, JW Kim - Neuropsychiatric Disease and Treatment, 2024 - Taylor & Francis
Purpose This study aimed to provide an objective means of predicting treatment responses
in patients with schizophrenia using quantitative electroencephalography (qEEG) as an …

Biological Characteristics of Treatment Outcomes in Schizophrenia

M Das, S Chakraborty, N Das, UM Mehta - … of the Biology and Pathology of …, 2024 - Springer
Schizophrenia is a chronic debilitating mental illness that has a lifetime prevalence of
approximately 1%. Despite extensive research, the exact etiopathogenesis of schizophrenia …

Анализ ЭЭГ покоя при шизофрении: от снижения альфа-ритма до оценки микросостояний

ИА Федотов, ДИ Шустов - ПСИХИАТРИЯ, 2024 - journalpsychiatry.com
Аннотация Обоснование: в связи с разработкой в последние годы новых технологий
анализа ЭЭГ появилось много новых работ в этой области, в том числе исследующих …